Richard Bedford

Richard Bedford has a diverse work experience in the pharmaceutical industry. Richard started their career as a Graduate Immunologist at Dstl in 1999. From there, they moved on to Sandoz as a Regulatory Affairs professional in 2002. In 2004, they joined Shire Pharmaceuticals as an Associate Director in Regulatory Affairs and later became a Senior Regulatory Affairs Manager at GW Pharmaceuticals in 2010. In 2015, they took on the role of Head of Regulatory Affairs at ONO Pharma UK Ltd, where they stayed until 2019. During that time, they also briefly worked as the Head of Regulatory Affairs at Colonis Pharma Limited in 2016. Currently, Richard is employed at KalVista Pharmaceuticals, Inc., where they started as the Director of Regulatory Affairs in 2019 and is now serving as the Senior Director of Regulatory Affairs since May 2022.

Richard Bedford attended Oxford Brookes University from 1996 to 1999, where they obtained a BSc(Hons) degree in Human Biology with a specialization in Immunology. Prior to their university studies, Richard attended Southend High School, although no specific degree or field of study is mentioned for this institution.